Inhibitior of Bcl6 by FX1 protects DSS induced colitis mice through anti-inflammatory effects
IntroductionInflammatory bowel disease (IBD) is a complex immune-mediated condition, and biologics are the most commonly used drugs for its treatment. However, there are still cases of ineffective treatment. B-cell lymphoma 6 (Bcl6), a transcriptional …